(Journal of affective disorders[TA])
22,132 results
  • Using stakeholder-weighted outcomes in depression trials. [Journal Article]
    J Affect Disord. 2026 Oct 29; :122682. [Online ahead of print]Molloy N, Jin H, Wykes DTJA
  • Mental health randomised controlled trials (RCTs) base treatment benefit on a sole primary outcome, that is typically symptom-based in depression trials. However, research with stakeholders, including service-users and clinicians, often reports that although symptoms are important, but other domains such as quality-of-life, social, and occupational functioning are also prioritised. This evidence …
  • The role of Family Focused Therapy in bipolar disorder: A narrative review of evidence. [Review]
    J Affect Disord. 2026 Oct 27; :122667. [Online ahead of print]Oliva A, Scatà C, … Delvecchio GJA
  • CONCLUSIONS: FFT has been proven effective when combined with pharmacological treatment for BD, particularly in improving psychosocial functioning and reducing clinical instability. Its emphasis on family dynamics provides a promising approach to comprehensive management of BD. Further research is needed to assess long-term outcomes and refine treatment protocols for broader clinical application.
  • Low-dose ketamine modulates brain entropy in treatment-resistant depression: Results from two neuroimaging clinical trials. [Journal Article]
    J Affect Disord. 2026 Oct 26; 417:122673. [Online ahead of print]Liou YJ, Cheng LK, … Chen MHJA
  • CONCLUSIONS: Low-dose ketamine rapidly increases brain entropy (from baseline to day 3) in frontolimbic, cerebellar, and ascending neuromodulatory regions, including the gyrus rectus, cerebellar vermis I/II, substantia nigra, red nucleus, bilateral locus coeruleus, and left amygdala. Changes in brain entropy after low-dose ketamine infusion may be associated with its rapid antidepressant and antianhedonic effects, although this relationship requires further investigation.